New CRG Report: Genetic Privacy and Non-Forensic Biobanks
By Council for Responsible Genetics,
Council for Responsible Genetics
| 08. 12. 2014
The current structure of biobanks in the United States is missing substantial federal and state policies to address and resolve people’s privacy concerns as well as sufficient education for people about the laws that are there to protect their genetic privacy. Medical, research, and commercial DNA databases all generate privacy concerns largely because of the misunderstanding between what people anticipate from giving their genetic information to these biobanks and what actually occurs. Because of the various risks that are associated with non-forensic biobanks, it is necessary to have stringent regulations and federal oversight so that scientists may be able to use donated genetic data to research diseases without compromising the genetic privacy of donors as well as their close relatives.
The new CRG report: Do You Know Where Your DNA Is? Genetic Privacy and Non-Forensic Biobanks explores the various forms of biobanks in the US, their privacy limitations, the current state of regulation and the need for reform.
The report can be accessed at the following link and on the homepage of the CRG website: http://www.councilforresponsiblegenetics.org/pageDocuments/L0Z6I8MLM3.pdf
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...